⌘K
t
Anita Hyman, a person closely associated with BioPharma Credit PLC Director Harry Hyman, purchased 62 ordinary shares in BioPharma Credit PLC. This transaction occurred on November 3, 2025, at a price of £0.693518 per share, as part of a dividend reinvestment.
| Date | 4 Nov 2025 |
| Time | 15:29:53 |
| Category | Director/PDMR dealings |
| ID | 1680G |
4 November 2025
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
|
1. |
Details of person discharging managerial responsibilities/person closely associated with them |
||||||
|
a) |
Name |
Anita Hyman |
|||||
|
2. |
Reason for the notification |
||||||
|
a) |
Position / status |
Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) |
|||||
|
b) |
Initial notification / amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
BioPharma Credit PLC |
|||||
|
b) |
LEI |
213800AV55PYXAS7SY24 |
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of $0.01 each
GB00BDGKMY29 |
|||||
|
b) |
Nature of the transaction |
Purchase of Shares (acquired as part of dividend reinvestment) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume
- Price |
N/A
|
|||||
|
e) |
Date of the transaction |
03.11.2025 |
|||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||